Bjork Elisabeth bought RCKT
August 27, 2025 · Form 4 insider transaction
Bjork Elisabeth bought 10,000 shares of Rocket Pharmaceuticals, Inc. at $3.41 per share, a transaction worth $34.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$3.41
Total value
$34.1K
InsiderBjork Elisabeth
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateAugust 27, 2025
Filing dateAugust 27, 2025
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026.